AMRS News
Archived Headlines
- Amyris Biotechnologies prices IPO at $16, below the proposed range 09/28/10
- 9 IPOs planned for the week of Sep 27 09/27/10
- Amyris Biotechnologies announces terms for upcoming IPO 09/13/10
- IPO activity rebounds: last week records highest number of filings since September 2007 04/19/10
- Industrial synthetics developer Amyris Biotechnologies files for $100 million IPO 04/16/10
US IPO Index concludes January, second best month since 2009
The FTSE Renaissance US IPO Index (IPOS) is coming off its second best monthly performance since April 2009, generating a 10.1% return in January. The US IPO Index strongly...read more
Chemical conversion specialist Mascoma files for a $100 million IPO
Mascoma Corporation,a developer of a platform to convert renewable feedstocks into chemicals used in alternative fuels, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The Lebanon, NH-based company, which was founded in...read more
Biochemicals maker Genomatica plans to go public
Genomatica, which has developed a platform to convert renewable feedstocks into chemicals used in various consumer products, including athletic apparel, running shoes, electronics and automobiles, filed an S-1 registration filing with the SEC on Wednesday. The...read more
KiOR prices IPO at $15, well below the proposed $19-$21 range
KiOR, which is developing a platform to convert non-food biomass into fuel blendstocks, raised a lower-than-expected $150 million by selling 10 million shares at $15.00, below its originally planned price range of $19 to $21. At its $15 offer price, KiOR will...read more